eszopiclone vs triazolam
PlainMeds reviewed this comparison against our methodology in August 2026. It places FDA and CMS record fields side by side, without recommending either medication.
Side-by-side comparison of eszopiclone and triazolam. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
Lunesta
Halcion
Eszopiclone (Lunesta) is a medicine that helps you fall asleep and stay asleep. It is used to treat insomnia.
Triazolam (Halcion) is a medication used for the short-term treatment of insomnia. It belongs to a class of drugs called benzodiazepines, which help you fall asleep.
Eszopiclone is used to treat insomnia, which means you have trouble falling asleep or staying asleep. It can help you fall asleep faster and stay asleep longer. Studies have shown it works for up to 6 months.
Triazolam is used to treat insomnia in adults. Insomnia is when you have trouble falling asleep or staying asleep. This medicine is only for short-term use, usually for 7 to 10 days.
Eszopiclone works by slowing down activity in your brain. This helps you relax and fall asleep. It affects certain chemicals in your brain that regulate sleep.
Triazolam works by slowing down activity in the brain. This helps you to relax and fall asleep. It affects certain chemicals in your brain called neurotransmitters.
- • Unpleasant taste
- • Headache
- • Feeling sleepy
- • Respiratory infection
- • Dizziness
- • Drowsiness
- • Headache
- • Dizziness
- • Nervousness
- • Light-headedness
- Insomnia 3,888
- Dysgeusia 3,854
- Nausea 1,382
- Middle Insomnia 1,213
- Fatigue 1,185
- Drug Abuse 519
- Sopor 402
- Nausea 352
- Overdose 350
- Fall 315
Eszopiclone can cause complex sleep behaviors like sleepwalking, sleep driving, and doing other activities while not fully awake. Some of these can lead to serious injuries or even death. Stop taking eszopiclone right away if this happens.
Taking triazolam with opioid pain medicines can cause very serious problems, including slowed or stopped breathing, coma, and death. Because of these risks, doctors will only prescribe opioid pain medicines with triazolam when other treatment options are not sufficient. Do not misuse this medicine. Misuse can lead to addiction, overdose, or death. Stopping triazolam suddenly can cause dangerous withdrawal symptoms. Talk to your doctor before stopping this medicine.
It is not known if eszopiclone can harm your unborn baby. Talk to your doctor if you are pregnant, plan to become pregnant, or are breastfeeding.
Taking triazolam late in pregnancy may cause sedation or withdrawal symptoms in the newborn. If you are pregnant or plan to become pregnant, talk to your doctor about the risks and benefits of taking triazolam. A registry exists to track outcomes in women who take psychiatric medications, including triazolam, during pregnancy.
Also Compare, Nearby Drugs
Compare eszopiclone with
Compare triazolam with
How to Read This eszopiclone vs triazolam Comparison
eszopiclone is classified in the Non-Benzodiazepine Hypnotic (Z-Drug) drug class, while triazolam sits within the Benzodiazepine (Hypnotic) class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, eszopiclone has 11,522 submissions while triazolam has 1,938. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for eszopiclone or triazolam.
Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.